The planned sites in Livonia, Las Vegas, and San Antonio would expand a partnership that places clinical research and health screenings inside Walmart stores.
|Webcasts|July 29, 2020
Improving Research Using the Physician, Patient Experience and Tech-Enabled Solutions
Author(s)Elligo
In this presentation, Elligo offers an overview of steps to reopen sites, both for those working on restarting existing programs and those looking to start new ones, by utilizing patient and principal investigator feedback from existing sites, using tech-enabled solutions and developing standard operating procedures to instill new best practices post-COVID-19 lockdown. On demand presentation Register free
Register Free:
Event Overview:
The COVID-19 pandemic brought most of the world to standstill, with quarantine making it difficult for physicians and patients to start new research programs within their practice or to restart their existing studies. As more healthcare practices open to provide care for their patients, what considerations need to be made to make sure healthcare workers and patients can access their treatments in a safe environment while keeping research programs compliant without compromising study quality or data integrity?
In this presentation, Elligo offers an overview of steps to reopen sites, both for those working on restarting existing programs and those looking to start new ones, by utilizing patient and principal investigator feedback from existing sites, using tech-enabled solutions and developing standard operating procedures to instill new best practices post-COVID-19 lockdown.
Key Learning Objectives:
Operational considerations and innovations for:
- How to know when a site is ready to reopen.
- Restarting research sites and studies that were in a lockdown environment due to COVID-19 in coordination with practice partners, study sponsors and CROs.
- Instilling a “back on track” mentality and available technology solutions across operations for enrollment and visits for on-hold or delayed studies.
Speakers: Faith Holmes, M.D., Medical Director, Elligo
Jacylyn Bodmer, Chief Information & Technology Officer, Elligo
Time and Date: On demand presentation
Sponsor: Elligo
Register Free:
Related to this article
In this video interview, Kent Thoelke, CEO of Paradigm Health, calls for safe harbor protections, CMS reimbursement safeguards, and funding mechanisms modeled on EHR meaningful use to help community and rural institutions participate in research on par with academic centers.
In today’s ACT Brief, we examine why community and rural patients lack access to research as a care option, what makes AI assistants trustworthy in regulated trials, and how FDA draft guidance could let gene editing therapies cover patient-specific variants.
In this Q&A, E.K. Koh, chief product officer at Suvoda, discusses what separates a trustworthy AI assistant from one that adds risk, why curated clinical knowledge matters more than general-purpose flexibility, and what safeguards must be in place when assistants move from answering questions to taking actions in clinical trial systems.
In this video interview, Kent Thoelke, CEO of Paradigm Health, explains why patients in community and rural settings too often lack access to clinical research as a care option, and how closing that gap could improve outcomes and lower long-term costs.
In today’s ACT Brief, we examine why anti-kickback guidance and EHR-integrated trial matching must work together in community settings, why real-time trials depend on mature risk-based quality management, and how pharma is applying digital clones to predict outcomes.
The FDA’s RTCT initiative transmits predefined, clinically meaningful signals to regulators during active trials, so its value depends entirely on the maturity of sponsors’ upstream RBQM signal intelligence, KRIs, QTLs, and root-cause context, rather than on data speed.
In this video interview, Kent Thoelke, CEO of Paradigm Health, outlines why anti-kickback guidance and modern EHR-integrated trial matching technology must work in tandem to reach representative patient populations at the community level.
Trending on Applied Clinical Trials Online
1
Building AI Assistants Clinical Trial Teams Can Trust: Q&A with E.K. Koh, Suvoda
2
Real-Time Continuous Trials Through the Lens of Risk-Based Quality Management: Why RBQM Is the Infrastructure RTCT Cannot Exist Without
3
What Needs to Happen Beyond the Clinical Trial Modernization Act
4
Closing the Medical Writing Capacity Gap: Why Training Beats Technology
5